Farallon Capital Management, L.L.C.
San Francisco, CA 91 processed 13Fs on this site, 2021 Q3 to 2026 Q3
- $23.2B
- 108 holdings
- 2026 Q3
- +7.1% QoQ
- Top 5 31.0%
Farallon Capital Management's biggest moves in 2026 Q3 were opening Warner Bros. Discovery and ROKU Inc, adding to Liquidia and Natera, trimming Lantheus and Tango Therapeutics, and selling out of Electronic Arts and CRNX.
AUM over time
Latest book
| RVMD, Revolution Medicines | Reduce −1.0% | 13,418,796 | $205.26 | $2.8B | −132,000 | +$217M | |
| WBD, Warner Bros. Discovery | New | 49,372,344 | $30.95 | $1.5B | +49,372,344 | +$1.5B | |
| NTRA, Natera | Add +17.2% | 2,599,648 | $413.31 | $1.1B | +381,282 | +$472M | |
| BBIO, BridgeBio Pharma | Add +32.6% | 14,247,000 | $65.80 | $937M | +3,503,937 | +$137M | |
| PTGX, Protagonist Therapeutics | Add +1.4% | 6,437,906 | $140.89 | $907M | +89,000 | +$129M | |
| EXEL, Exelixis | Add +9.1% | 14,694,910 | $58.41 | $858M | +1,226,900 | +$126M | |
| ROIV, Roivant Sciences | Add +52.0% | 21,745,533 | $36.57 | $795M | +7,436,533 | +$289M | |
| ROKU, ROKU Inc | New | 4,160,049 | $152.28 | $633M | +4,160,049 | +$633M | |
| AMZN, Amazon | Reduce −10.0% | 2,368,464 | $249.15 | $590M | −264,530 | −$37M | |
| GRAL, Grail | Reduce −2.2% | 4,069,233 | $140.12 | $570M | −92,351 | +$286M | |
| BSX, Boston Scientific | Add +7.3% | 11,287,164 | $43.65 | $493M | +765,980 | +$44M | |
| AVGO, Broadcom | Add +21.2% | 1,395,810 | $351.19 | $490M | +244,010 | +$55M | |
| CRH, CRH PLC | New | 5,341,100 | $82.80 | $442M | +5,341,100 | +$442M | |
| KVUE, Kenvue | New | 25,015,000 | $17.66 | $442M | +25,015,000 | +$442M | |
| TWST, Twist Bioscience | Hold | 2,136,400 | $193.24 | $413M | — | — | |
| UNH, UnitedHealth Group | Reduce −17.5% | 1,048,622 | $367.08 | $385M | −221,910 | −$143M | |
| MSFT, Microsoft | Reduce −34.1% | 733,563 | $512.90 | $376M | −379,300 | −$39M | |
| SNPS, Synopsys | Add +3.4% | 857,890 | $434.94 | $373M | +28,290 | +$3.1M | |
| KKR | Reduce −5.8% | 3,880,020 | $91.30 | $354M | −238,280 | −$24M | |
| AON, Aon | Reduce −10.3% | 1,239,672 | $276.77 | $343M | −142,890 | −$115M | |
| LNTH, Lantheus | Reduce −44.3% | 3,111,254 | $99.53 | $310M | −2,472,225 | −$310M | |
| TMO, Thermo Fisher Scientific | Reduce −57.5% | 445,685 | $675.05 | $301M | −603,500 | −$225M | |
| LQDA, Liquidia | Add +6.5% | 8,906,038 | $30.26 | $269M | +541,000 | −$397M | |
| WAB, Wabtec | Reduce −1.9% | 877,903 | $287.18 | $252M | −16,600 | +$11M | |
| BEAM, Beam Therapeutics | Add +0.4% | 10,276,396 | $24.45 | $251M | +40,000 | −$100M | |
| ARMK, Aramark | Add +27.0% | 4,606,431 | $53.55 | $247M | +980,700 | +$40M | |
| IMVT, Immunovant | Add +11.5% | 6,471,000 | $33.78 | $219M | +666,000 | −$5.1M | |
| AGIO, Agios Pharmaceuticals | Add +0.4% | 5,939,400 | $33.25 | $197M | +22,000 | −$22M | |
| BIIB, Biogen | Add +859.0% | 680,868 | $225.88 | $154M | +609,868 | +$138M | |
| JNJ, Johnson & Johnson | Add +17.8% | 480,426 | $264.74 | $127M | +72,426 | +$24M | |
| ACHC | Add +9.2% | 4,608,400 | $27.50 | $127M | +387,600 | +$2.1M | |
| BTSG, Brightspring Health Services | Add +17.9% | 2,043,800 | $56.75 | $116M | +311,000 | −$4.9M | |
| TNGX, Tango Therapeutics | Reduce −62.9% | 4,550,688 | $24.95 | $114M | −7,726,312 | −$270M | |
| BIDU, Baidu | Hold | 1,203,785 | $86.87 | $105M | — | — | |
| AIG, American Savings Bank NA | New | 4,557,082 | $17.89 | $82M | +4,557,082 | +$82M | |
| PBLS, Parabilis Medicines | Hold | 2,368,200 | $32.29 | $76M | — | — | |
| AZN, AstraZeneca | Reduce −23.3% | 440,000 | $161.47 | $71M | −134,000 | −$38M | |
| JOYY | Add +17.3% | 820,200 | $80.25 | $66M | +121,000 | +$20M | |
| AVTX, Avalo Therapeutics | Add +59.1% | 3,974,000 | $15.33 | $61M | +1,476,000 | +$15M | |
| FRNM, Freenome | New | 3,733,757 | $15.75 | $59M | +3,733,757 | +$59M | |
| IOND, Ionic Digital | New | 718,123 | $80.33 | $58M | +718,123 | +$58M | |
| GH, Guardant Health | Reduce −13.2% | 279,700 | $178.36 | $50M | −42,500 | +$1.5M | |
| ASMB, Assembly Biosciences | Hold | 1,604,590 | $23.49 | $38M | — | — | |
| NVS, Novartis | Reduce −29.8% | 255,000 | $142.57 | $36M | −108,000 | −$21M | |
| MAZE, Maze Therapeutics | Hold | 1,107,814 | $27.18 | $30M | — | — | |
| LBRX, LB Pharmaceuticals | New | 741,410 | $38.38 | $28M | +741,410 | +$28M | |
| Immunocore | New | 928,000 | $30.29 | $28M | +928,000 | +$28M | |
| ASML | New | 13,518 | $1,812 | $24M | +13,518 | +$24M | |
| RIO, Rio Tinto | Add +19.3% | 218,899 | $94.17 | $21M | +35,424 | +$3.2M | |
| BABA, Alibaba | New | 189,000 | $107.54 | $20M | +189,000 | +$20M | |
| Electra Therapeutics | New | 1,700,000 | $11.25 | $19M | +1,700,000 | +$19M | |
| ALVO, Alvotech | Hold | 2,859,675 | $5.80 | $17M | — | — | |
| INDV, Indivior Pharmaceuticals | New | 447,620 | $35.85 | $16M | +447,620 | +$16M | |
| ALMR, Alamar Biosciences | Hold | 462,900 | $34.07 | $16M | — | — | |
| NTES, NetEase | Hold | 123,500 | $121.16 | $15M | — | — | |
| Latigo Biotrapeutics | New | 850,000 | $16.70 | $14M | +850,000 | +$14M | |
| ABVX, Abivax | Add +14.8% | 140,000 | $99.02 | $14M | +18,000 | −$2.4M | |
| KLRA, Kailera Therapeutics | Hold | 1,100,000 | $11.42 | $13M | — | — | |
| ENTA, Enanta Pharmaceuticals | Reduce −60.7% | 950,000 | $13.18 | $13M | −1,468,202 | −$23M | |
| VNET, Vnet Group | Add +1.7% | 2,025,000 | $5.55 | $11M | +33,000 | −$4.8M | |
| TSHA, Taysha Gene Therapies | Reduce 0.0% | 2,249,000 | $4.87 | $11M | −1,000 | −$4.4M | |
| NERV, Minerva Neurosciences | Hold | 2,365,000 | $3.35 | $7.9M | — | — | |
| Scribe Therapeutics | New | 380,000 | $18.40 | $7M | +380,000 | +$7M | |
| COHU | New | 91,000 | $68.14 | $6.2M | +91,000 | +$6.2M | |
| IFRX, Inflarx | Reduce −0.5% | 3,310,000 | $1.80 | $6M | −15,000 | −$1.5M | |
| ENTG, Entegris | New | 37,000 | $154.06 | $5.7M | +37,000 | +$5.7M | |
| Braveheart Bio | New | 277,778 | $20.20 | $5.6M | +277,778 | +$5.6M | |
| CLS, Celestica | New | 15,000 | $361.43 | $5.4M | +15,000 | +$5.4M | |
| Revvity | New | 35,000 | $152.89 | $5.4M | +35,000 | +$5.4M | |
| VEEV, Veeva Systems | New | 18,500 | $285.45 | $5.3M | +18,500 | +$5.3M | |
| ROK, Rockwell Automation | New | 12,000 | $435.33 | $5.2M | +12,000 | +$5.2M | |
| Gates Industrial | New | 196,000 | $26.20 | $5.1M | +196,000 | +$5.1M | |
| Mcgraw Hill | New | 389,000 | $13.11 | $5.1M | +389,000 | +$5.1M | |
| ECL, Ecolab | New | 18,500 | $274.58 | $5.1M | +18,500 | +$5.1M | |
| Worthington Enterprises | New | 85,000 | $59.54 | $5.1M | +85,000 | +$5.1M | |
| ATI, ATI Inc | New | 26,500 | $189.40 | $5M | +26,500 | +$5M | |
| BLDR, Builders FirstSource | New | 87,000 | $57.01 | $5M | +87,000 | +$5M | |
| NKE, Nike | New | 140,000 | $35.40 | $5M | +140,000 | +$5M | |
| RPM, RPM International | New | 50,000 | $98.67 | $4.9M | +50,000 | +$4.9M | |
| ELPC | New | 395,000 | $12.42 | $4.9M | +395,000 | +$4.9M | |
| MGA, Magna International | New | 77,000 | $63.67 | $4.9M | +77,000 | +$4.9M | |
| Woodside Energy Group | New | 220,000 | $22.17 | $4.9M | +220,000 | +$4.9M | |
| MOD, Modine Manufacturing | New | 26,000 | $187.20 | $4.9M | +26,000 | +$4.9M | |
| FDS, FactSet | New | 18,000 | $269.95 | $4.9M | +18,000 | +$4.9M | |
| NXT, Nextpower | New | 62,000 | $77.93 | $4.8M | +62,000 | +$4.8M | |
| Vesta Real Estate | New | 150,000 | $32.18 | $4.8M | +150,000 | +$4.8M | |
| EXPD, Expeditors International Wash | New | 26,000 | $184.64 | $4.8M | +26,000 | +$4.8M | |
| GXO, Gxo Logistics | New | 108,000 | $44.45 | $4.8M | +108,000 | +$4.8M | |
| KBR, KBR Inc | New | 136,000 | $35.16 | $4.8M | +136,000 | +$4.8M | |
| FLEX, Flextronics | New | 43,000 | $109.99 | $4.7M | +43,000 | +$4.7M | |
| GWRE, Guidewire Software | New | 33,000 | $142.58 | $4.7M | +33,000 | +$4.7M | |
| KHC, Kraft Heinz | New | 206,000 | $22.72 | $4.7M | +206,000 | +$4.7M | |
| BVN | New | 148,000 | $31.58 | $4.7M | +148,000 | +$4.7M | |
| LMND, Lemonade | New | 103,000 | $45.14 | $4.6M | +103,000 | +$4.6M | |
| Telix Pharmaceutical | New | 419,000 | $10.97 | $4.6M | +419,000 | +$4.6M | |
| MOBI, Mobia Medical | Reduce −61.2% | 437,828 | $9.45 | $4.1M | −690,729 | −$11M | |
| SGMT, Sagimet Biosciences | Reduce −3.6% | 400,000 | $9.88 | $4M | −15,000 | +$744K | |
| JATT, Jatt III Acquisition | New | 350,000 | $11.16 | $3.9M | +350,000 | +$3.9M | |
| GSHD, Goosehead Insurance | New | 84,000 | $45.36 | $3.8M | +84,000 | +$3.8M | |
| PRME, Prime Medicine | Hold | 1,240,843 | $3.05 | $3.8M | — | — | |
| JATT, Jatt II Acquisition | Hold | 300,000 | $11.12 | $3.3M | — | — | |
| SMC, Summit Midstream | Hold | 58,214 | $30.23 | $1.8M | — | — | |
| COGT, Cogent Biosciences | Hold | 17,000 | $32.02 | $544K | — | — | |
| WELL, Welltower | Hold | 1,000 | $230.24 | $230K | — | — | |
| PACB | Hold | 14,200 | $2.37 | $34K | — | — | |
| GERN, Geron | Hold | 14,400 | $1.23 | $18K | — | — | |
| RANI, Rani Therapeutics | Hold | 20,700 | $0.7910 | $16K | — | — | |
| CGC, Canopy Growth | Hold | 18,000 | $0.8962 | $16K | — | — |
Showing top 50 of 108 by value
Exits / last held
Gone since 2026 Q2, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| EA, Electronic Arts | Exit | 0 | $205.04 | $1.6B | −7,919,500 | −$1.6B | |
| CRNX | Exit | 0 | $37.42 | $336M | −8,989,098 | −$336M | |
| NVO, Novo Nordisk | Exit | 0 | $47.94 | $126M | −2,619,000 | −$126M | |
| MRK, Merck | Exit | 0 | $128.50 | $26M | −199,000 | −$26M | |
| WRBY, Warby Parker | Exit | 0 | $30.34 | $25M | −828,000 | −$25M | |
| PCSC, Perceptive Cap Solutions | Exit | 0 | $10.88 | $24M | −2,250,000 | −$24M | |
| AXTA, Axalta Coating Systems | Exit | 0 | $34.22 | $16M | −478,000 | −$16M | |
| BBNX, Beta Bionics | Exit | 0 | $15.67 | $9.3M | −595,000 | −$9.3M | |
| SMG, Scotts Miracle-Gro | Exit | 0 | $68.11 | $6M | −88,000 | −$6M | |
| WAY, Waystar | Exit | 0 | $20.53 | $5.4M | −264,900 | −$5.4M | |
| BC, Brunswick | Exit | 0 | $84.25 | $5.1M | −61,000 | −$5.1M | |
| GNTX, Gentex | Exit | 0 | $25.27 | $5M | −199,000 | −$5M | |
| IDXX, Idexx Laboratories | Exit | 0 | $526.44 | $4.7M | −9,000 | −$4.7M | |
| CMC, Commercial Metals | Exit | 0 | $62.75 | $4.2M | −67,000 | −$4.2M | |
| TEVA, Teva Pharmaceutical Industries | Exit | 0 | $33.88 | $1.4M | −40,000 | −$1.4M | |
| ANNA, Aleanna | Exit | 0 | $2.90 | $227K | −78,400 | −$227K | |
| BYND, Beyond Meat | Exit | 0 | $0.7368 | $14K | −19,000 | −$14K |
Filings history
21 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q3 | 116 | $23.2B | +7.1% | 13F-HR | 11/16/2026 | 000090883426000540 |
| 2026 Q2 | 3 | $1.4B | — | new holds | 11/16/2026 | 000090883426000544 |
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 2 | $1.4B | — | new holds | 11/16/2026 | 000090883426000542 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 2 | $1B | — | new holds | 11/16/2026 | 000090883426000546 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
Farallon Capital Management, L.L.C.
91 processed 13Fs on this site, 2021 Q3 to 2026 Q3
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon